Mark Spring

Mark E.
Spring was the founder of Secura Bio, Inc., founded in 2019, where the title held was Chief Financial Officer from 2019 to 2023.
The current job is at Artelo Biosciences, Inc. starting in 2024, holding the titles of CFO, Treasurer & Chief Accounting Officer beginning in 2025.
Former jobs include Vice President-Finance at Baxter International, Inc. in 2004; Vice President-Finance & Controller at MedImmune LLC from 2004 to 2007; Principal at Caremark International, Inc.; Principal at PricewaterhouseCoopers LLP; Chief Financial Officer at Sotera Wireless, Inc. from 2013 to 2017; Chief Financial Officer & Senior Vice President at Hyperion Therapeutics, Inc. in 2008; Principal at Dade Behring, Inc.; Chief Financial Officer & SVP-Finance at Prometheus RxDx, Inc.; Chief Financial Officer at Genoptix, Inc. from 2017 to 2018; Chief Financial Officer at Veracyte, Inc. from 2012 to 2013; Chief Financial Officer at LENZ Therapeutics, Inc.; and Chief Financial Officer & Senior Vice President at Prometheus Laboratories, Inc. from 2008 to 2011.
Education includes undergraduate studies at Monmouth College.